{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:33:53Z","timestamp":1783020833541,"version":"3.54.6"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) contributes to the development of ischemic heart disease via multiple mechanisms. Fatty liver index (FLI) has been proposed as an accurate, convenient, and economic surrogate of the severity of NAFLD. Our present study aims to assess the association between FLI and the prevalent IHD and to evaluate the potential value of FLI to refine the detection of prevalent IHD in the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Our work recruited 32,938 subjects from the National Health and Nutrition Examination Survey 1999\u20132016. IHD was diagnosed according to the subjects\u2019 self-report. FLI was determined based on triglycerides, BMI, <jats:italic>\u03b3<\/jats:italic>-glutamyltransferase, and waist circumference.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>2,370 (7.20%) subjects were diagnosed with IHD. After adjustment of age, sex, race, current smoking, current drinking, PIR, BMI, WC, TC, TG, GGT, Scr, FPG, SBP, anti-hypertensive therapy, anti-diabetic therapy, and lipid-lowering therapy, one standard deviation increase of FLI resulted in a 27.0% increment of the risk of prevalent IHD. In the quartile analysis, we observed a 1.684 times risk of prevalent IHD when comparing the fourth quartile with the first quartile, and there was a trend towards higher risk across the quartiles. The smooth curve fitting displayed a linear relationship between FLI and the presence of IHD without any threshold or saturation effect. Subgroup analysis revealed a robust association in conventional cardiovascular subpopulations, and the association could be more prominent in female subjects and diabetes patients. ROC analysis demonstrated an incremental value of FLI for detecting prevalent IHD after introducing it to conventional cardiovascular risk factors (AUC: 0.823 vs. 0.859, <jats:italic>P<\/jats:italic> for comparison &amp;lt;0.001). Also, results from reclassification analysis implicated that more IHD patients could be correctly identified by introducing FLI into conventional cardiovascular risk factors (continuous net reclassification index: 0.633, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001; integrated discrimination index: 0.034, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The current analysis revealed a positive and linear relationship between FLI and the prevalent IHD. Furthermore, our findings suggest the incremental value of FLI to refine the detection of prevalent IHD in the general population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1171754","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T08:39:51Z","timestamp":1697099991000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Significance of fatty liver index to detect prevalent ischemic heart disease: evidence from national health and nutrition examination survey 1999\u20132016"],"prefix":"10.3389","volume":"10","author":[{"given":"Yuyu","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/s0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (nafld) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"Nafld and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","article-title":"Non-alcoholic fatty liver disease and risk of cardiovascular disease","volume":"65","author":"Lonardo","year":"2016","journal-title":"Metab Clin Exp"},{"key":"B6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Non-alcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: an analysis of the framingham heart study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/gutjnl-2016-311854","article-title":"Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study","volume":"66","author":"Sinn","year":"2017","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9933","DOI":"10.1038\/s41598-017-09851-5","article-title":"Non-alcoholic fatty liver disease and coronary artery calcification in a northern Chinese population: a cross sectional study","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.25555","article-title":"Fatty liver index, gamma-glutamyltransferase, and early carotid plaques","volume":"55","author":"Kozakova","year":"2012","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Non-alcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230x-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","article-title":"Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study","volume":"19","author":"Kim","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.7150\/ijms.62010","article-title":"Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.3390\/ijerph17249568","article-title":"The association between non-alcoholic fatty liver disease and stroke: results from the Korean genome and epidemiology study (koges)","volume":"17","author":"Yang","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/diacare.26.2007.s5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes Mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (jnc 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/circulationaha.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2215\/cjn.09590911","article-title":"New metrics for assessing diagnostic potential of candidate biomarkers","volume":"7","author":"Pickering","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the roc curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085.","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.athoracsur.2014.10.084","article-title":"Net reclassification Index: measuring the incremental value of adding a new risk factor to an existing risk model","volume":"99","author":"Grunkemeier","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e031420","DOI":"10.1136\/bmjopen-2019-031420","article-title":"Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the kuopio ischaemic heart disease risk factor study cohort","volume":"9","author":"Olubamwo","year":"2019","journal-title":"BMJ Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1069146","DOI":"10.3389\/fcvm.2022.1069146","article-title":"Association between weight-adjusted-waist index and heart failure: results from national health and nutrition examination survey 1999-2018","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.metabol.2010.07.027","article-title":"Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven non-alcoholic fatty liver disease","volume":"60","author":"Kasumov","year":"2011","journal-title":"Metab Clin Exp"},{"key":"B29","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1365-2265.2012.04460.x","article-title":"Plasma fetuin-a is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with non-alcoholic fatty liver disease","volume":"78","author":"Dogru","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/jgh.12549","article-title":"Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease","volume":"29","author":"Elsheikh","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"21202","DOI":"10.3390\/ijms151121202","article-title":"Plasma levels of homocysteine and cysteine increased in pediatric nafld and strongly correlated with severity of liver damage","volume":"15","author":"Pastore","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with non-alcoholic fatty liver disease (nafld)","volume":"40","author":"Madan","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2013-09-512749","article-title":"Oxidative stress in angiogenesis and vascular disease","volume":"123","author":"Kim","year":"2014","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.clinbiochem.2013.05.070","article-title":"Inflammatory biomarkers for predicting cardiovascular disease","volume":"46","author":"Stoner","year":"2013","journal-title":"Clin Biochem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1007\/s10620-009-1075-y","article-title":"The inflamed liver and atherosclerosis: a link between histologic severity of non-alcoholic fatty liver disease and increased cardiovascular risk","volume":"55","author":"Alkhouri","year":"2010","journal-title":"Dig Dis Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.10.009","article-title":"Lipoproteins as modulators of atherothrombosis: from endothelial function to primary and secondary coagulation","volume":"82","author":"Ouweneel","year":"2016","journal-title":"Vascul Pharmacol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1171754\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T08:39:53Z","timestamp":1697099993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1171754\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2023.1171754"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1171754","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"article-number":"1171754"}}